Literature DB >> 19028204

Gender differences in office and ambulatory control of hypertension.

José R Banegas1, Julián Segura, Alejandro de la Sierra, Manuel Gorostidi, Fernando Rodríguez-Artalejo, Javier Sobrino, Juan J de la Cruz, Ernest Vinyoles, Raquel Hernández del Rey, Auxiliadora Graciani, Luis M Ruilope.   

Abstract

BACKGROUND: Gender differences in hypertension control have not been explored fully.
METHODS: We studied 15,212 white men and 13,936 white women with treated hypertension who were drawn from the Spanish Ambulatory Blood Pressure Registry. For each participant, we obtained office blood pressure (BP) (average of 2 readings) and 24-hour ambulatory BP (average of measurements performed every 20 minutes during day and night).
RESULTS: Only 16.4% of women and 14.7% of men had both office (<140/90 mm Hg) and ambulatory (<130/80 mm Hg) BP controlled (P<.001). Women had a lower frequency of masked hypertension (office BP<140/90 mm Hg and ambulatory BP> or =130/80 mm Hg) than men (5.9% vs 7.9%, P<.001). Women had a higher frequency of isolated office hypertension (office BP> or =140/90 mm Hg and ambulatory BP<130/80 mm Hg) (32.5% vs 24.2%, P<.001). Although office BP control (office BP<140/90 mm Hg, regardless of ambulatory values) was similar in women and men (22.3% vs 22.6%, P=.542), ambulatory BP control (ambulatory BP<130/80 mm Hg, regardless of office values) was higher in women than in men (48.9% vs 38.9%, P<.001). After adjustment for age, number of antihypertensive drugs, hypertension duration, and risk factors, gender differences in BP control remained practically unchanged.
CONCLUSION: Ambulatory BP control was higher in women than in men. This may be due to the higher frequency of isolated office hypertension in women, and it is not explained by gender differences in other important clinical characteristics.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19028204     DOI: 10.1016/j.amjmed.2008.06.037

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  6 in total

Review 1.  Prevalence of white-coat and masked hypertension in national and international registries.

Authors:  Manuel Gorostidi; Ernest Vinyoles; José R Banegas; Alejandro de la Sierra
Journal:  Hypertens Res       Date:  2014-10-16       Impact factor: 3.872

2.  Gender disparities in the pharmacological treatment of cardiovascular disease and diabetes mellitus in the very old: an epidemiological, cross-sectional survey.

Authors:  Jon Brännström; Katarina Hamberg; Lena Molander; Hugo Lövheim; Yngve Gustafson
Journal:  Drugs Aging       Date:  2011-12-01       Impact factor: 3.923

3.  Night blood pressure responses to atenolol and hydrochlorothiazide in black and white patients with essential hypertension.

Authors:  Arlene B Chapman; George Cotsonis; Vishal Parekh; Gary L Schwartz; Yan Gong; Kent R Bailey; Stephen T Turner; John G Gums; Amber L Beitelshees; Rhonda Cooper-DeHoff; Eric Boerwinkle; Julie A Johnson
Journal:  Am J Hypertens       Date:  2013-07-25       Impact factor: 2.689

Review 4.  Women-specific factors to consider in risk, diagnosis and treatment of cardiovascular disease.

Authors:  Ronée E Harvey; Kirsten E Coffman; Virginia M Miller
Journal:  Womens Health (Lond)       Date:  2015-03

5.  Recent advances in the management of hypertension.

Authors:  José Antonio García-Donaire; Luis M Ruilope
Journal:  F1000 Med Rep       Date:  2010-03-15

6.  Self-reported diet management, dietary quality, and blood pressure control in Korean adults with hypertension.

Authors:  Jee-Seon Shim; Sun Jae Jung; Hyeon Chang Kim
Journal:  Clin Hypertens       Date:  2019-12-15
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.